Compound 875
Identifiers
- Canonical SMILES:
CC(C)C1=C(SC2=N[C@](C)([C@H](N12)c1ccc(Cl)cc1)c1ccc(Cl)cc1)C(=O)N1CCC[C@H]1c1nnc(C)o1
- IUPAC name:
[(5R,6S)-5,6-bis(4-chlorophenyl)-6-methyl-3-propan-2-yl-5H-imidazo[2,1-b][1,3]thiazol-2-yl]-[(2S)-2-(5-methyl-1,3,4-oxadiazol-2-yl)pyrrolidin-1-yl]methanone
- InChi:
InChI=1S/C29H29Cl2N5O2S/c1-16(2)23-24(27(37)35-15-5-6-22(35)26-34-33-17(3)38-26)39-28-32-29(4,19-9-13-21(31)14-10-19)25(36(23)28)18-7-11-20(30)12-8-18/h7-14,16,22,25H,5-6,15H2,1-4H3/t22-,25+,29-/m0/s1
- InChiKey:
RBSUVUCANRWZSG-HQQGYVGFSA-N
External links
58007288 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MDM2-Like / P53 | 8.00 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 581.14 g/mol | |||
HBA | 7 | |||
HBD | 0 | |||
HBA + HBD | 7 | |||
AlogP | 5.27 | |||
TPSA | 74.83 | |||
RB | 5 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2008072655 | 97 | MDM2 Q00987 |
|
Biochemical assay | Time-Resolved FRET | pIC50 (half maximal inhibitory concentration, -log10) | 8.00 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.3624 | RO-5045337 | DB14793 | |
0.3570 | Br-Coeleneterazine | DB02006 | |
0.3558 | ONC-201 | DB14844 | |
0.3556 | (5Z)-5-[(5-ethylfuran-2-yl)methylidene]-2-[[(S)-(4-fluorophenyl)-(2H-tetrazol-5-yl)methyl]amino]-1,3-thiazol-4-one | DB08710 | |
0.3518 | N-Coeleneterazine | DB04118 | |
0.3517 | I-Coeleneterazine | DB04146 | |
0.3509 | Cp-Coeleneterazine | DB03960 | |
0.3506 | Cis-[4,5-Bis-(4-Chlorophenyl)-2-(2-Isopropoxy-4-Methoxyphenyl)-4,5-Dihyd Roimidazol-1-Yl]-Piperazin-1-Yl-Methanone | DB04144 | |
0.3460 | Levamisole | DB00848 | |
0.3419 | Cefiderocol | DB14879 | |
0.3399 | (2S)-({(5Z)-5-[(5-Ethyl-2-furyl)methylene]-4-oxo-4,5-dihydro-1,3-thiazol-2-yl}amino)(4-fluorophenyl)acetic acid | DB08706 | |
0.3299 | 8-Benzyl-2-Hydroperoxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One | DB02241 | |
0.3258 | Cis-[4,5-Bis-(4-Bromophenyl)-2-(2-Ethoxy-4-Methoxyphenyl)-4,5-Dihydroimidazol-1-Yl]-[4-(2-Hydroxyethyl)Piperazin-1-Yl]Methanone | DB02872 | |
0.3242 | Cephalosporin analog | DB02136 | |
0.3238 | 8-Benzyl-2-Hydroxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One | DB02194 |